The authors thank Anne Kurtenbach (University of Tuebingen) for her continuous help in preparation, Apostoulos Bezirgiannidis for his efforts in support of the surgical procedures, and all employees of Labcorp (Muenster) for their careful and hard work.
Supported by the Tistou & Charlotte Kerstan Foundation.
Study Group Authorship—Members of the RD-CURE Consortium (in institutional and alphabetical order): Karl Ulrich Bartz-Schmidt, Sylvia Bolz, Dominik Fischer, Susanne Kohl, Laura Kühlewein, Regine Mühlfriedel, Jonas Neubauer, Alex Ochakovski, Francois Paquet-Durand, Mathias Seeliger, Vithiyanjali Sothilingam, Katharina Stingl, Marius Ueffing, Nicole Weisschuh, Bernd Wissinger, Fabian Wozar, Ahmad Zhour, Ditta Zobor, and Eberhart Zrenner (Centre for Ophthalmology, University of Tuebingen, Germany); Stylianos Michalakis (Department of Ophthalmology, University Hospital, LMU Munich); Martin Biel and Christian Schön (Department of Pharmacy—Center for Drug Research, Ludwig-Maximilians-Universität München, Germany); Nadine Kahle, Tobias Peters, and Barbara Wilhelm (STZ eyetrial at the Centre for Ophthalmology, University of Tübingen, Germany); Steven Tsang (Department of Ophthalmology, Columbia University, NY, USA); and Christian Johannes Glöckner (Deutsches Zentrum für Neurodegenerative Erkrankungen, Tuebingen, Germany).
Disclosure: I.P. Seitz, None; F. Wozar, None; G.A. Ochakovski, None; F.F. Reichel, None; S. Korte, None; B. Korbmacher, None; B. Wilhelm, None; D. Süsskind, None; K.U. Bartz-Schmidt, None; M.D. Fischer, None; T. Peters, None